These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 30995806)

  • 21. Intestinal homeostasis and its breakdown in inflammatory bowel disease.
    Maloy KJ; Powrie F
    Nature; 2011 Jun; 474(7351):298-306. PubMed ID: 21677746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial barrier: an interface for the cross-communication between gut flora and immune system.
    Goto Y; Kiyono H
    Immunol Rev; 2012 Jan; 245(1):147-63. PubMed ID: 22168418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
    Vanderpool C; Yan F; Polk DB
    Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of FoxO4 in the relationship between alcohol-induced intestinal barrier dysfunction and liver injury.
    Chang B; Sang L; Wang Y; Tong J; Wang B
    Int J Mol Med; 2013 Mar; 31(3):569-76. PubMed ID: 23292333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.
    Andoh A; Fujiyama Y
    World J Gastroenterol; 2006 Jul; 12(28):4452-60. PubMed ID: 16874854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia inducible factor-1α-induced interleukin-33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease.
    Sun M; He C; Wu W; Zhou G; Liu F; Cong Y; Liu Z
    Clin Exp Immunol; 2017 Mar; 187(3):428-440. PubMed ID: 27921309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation and pathophysiological role of epithelial turnover in the gut.
    Günther C; Buchen B; Neurath MF; Becker C
    Semin Cell Dev Biol; 2014 Nov; 35():40-50. PubMed ID: 24973733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of Zinc and Zinc Transporters in the Pathogenesis of Inflammatory Bowel Diseases.
    Ohashi W; Fukada T
    J Immunol Res; 2019; 2019():8396878. PubMed ID: 30984791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functions of Macrophages in the Maintenance of Intestinal Homeostasis.
    Wang S; Ye Q; Zeng X; Qiao S
    J Immunol Res; 2019; 2019():1512969. PubMed ID: 31011585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kaempferol inhibits multiple pathways involved in the secretion of inflammatory mediators from LPS‑induced rat intestinal microvascular endothelial cells.
    Bian Y; Liu P; Zhong J; Hu Y; Fan Y; Zhuang S; Liu Z
    Mol Med Rep; 2019 Mar; 19(3):1958-1964. PubMed ID: 30569099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of programmed necrosis and cell death in intestinal inflammation.
    Dagenais M; Douglas T; Saleh M
    Curr Opin Gastroenterol; 2014 Nov; 30(6):566-75. PubMed ID: 25291357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-TNF-
    Zhang C; Shu W; Zhou G; Lin J; Chu F; Wu H; Liu Z
    Mediators Inflamm; 2018; 2018():3021863. PubMed ID: 30595666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.
    Lissner D; Schumann M; Batra A; Kredel LI; Kühl AA; Erben U; May C; Schulzke JD; Siegmund B
    Inflamm Bowel Dis; 2015 Jun; 21(6):1297-305. PubMed ID: 25901973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epithelial cell in intestinal homeostasis and inflammatory bowel diseases].
    Zouiten-Mekki L; Serghini M; Fekih M; Kallel L; Matri S; Ben Mustapha N; Boubaker J; Filali A
    Med Sci (Paris); 2013 Dec; 29(12):1145-50. PubMed ID: 24356146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of homeostasis and inflammation in the intestine.
    MacDonald TT; Monteleone I; Fantini MC; Monteleone G
    Gastroenterology; 2011 May; 140(6):1768-75. PubMed ID: 21530743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal Macrophages in Resolving Inflammation.
    Hine AM; Loke P
    J Immunol; 2019 Aug; 203(3):593-599. PubMed ID: 31332080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis.
    Petito V; Graziani C; Lopetuso LR; Fossati M; Battaglia A; Arena V; Scannone D; Quaranta G; Quagliariello A; Del Chierico F; Putignani L; Masucci L; Sanguinetti M; Sgambato A; Gasbarrini A; Scaldaferri F
    World J Gastroenterol; 2019 Mar; 25(12):1465-1477. PubMed ID: 30948910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity.
    Contreras TC; Ricciardi E; Cremonini E; Oteiza PI
    Arch Biochem Biophys; 2015 May; 573():84-91. PubMed ID: 25795020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.